Patients with comorbidities need tailored approaches to address their specific needs
The Science-Backed Benefits of AOD-9604 Clinical data on AOD9604 is mixed, but there are a few real, evidence-backed mechanisms worth understanding: May Support Fat Breakdown (Lipolysis) AOD9604 mimics a small fragment of human growth hormone (HGH), specifically the region responsible for fat metabolism
As with any peptide, there could be risks, such as injection site reactions, water retention, or possible changes in insulin sensitivity
The clinical presentation can be insidious, with symptoms developing so gradually that patients may not recognise the changes until deficiency becomes severe
The increased NAD+ levels activate SIRT1, a protein that plays a crucial role in regulating insulin sensitivity and glucose metabolism